Qiming-Backed Berry Genomics Eyes IPO Via Back-Door Listing

For Digital Subscribers Only

Berry Genomics, a Chinese genetic testing firm backed by Qiming Venture Partners and Legend Capital, is seeking to list in the A-share market via a reverse merger with Shenzhen-listed Chengdu Tianxing Instrument & Meter, according to a disclosure filing (in Chinese).

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY